Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors

Sandeep P. Dave, Anthony Bared, Roy R Casiano

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Objective: To report the surgical outcomes and safety of transnasal endoscopic resection (TER) for anterior skull base (ASB) tumors. Study Design and Setting: A retrospective chart review to identify patients undergoing TER for ASB tumors at a tertiary care medical center between September 1997 and June 2006. Results: Nineteen patients underwent TER for ASB tumors without open craniotomy. There were 17 malignant and two benign lesions. Olfactory neuroblastoma was the most common pathology, occurring in 53 percent of patients. One patient recurred locally, resulting in an overall local control rate of 94.7 percent for all neoplasms and 94.1 percent for malignant disease. It should be noted that the tumor control rate may be premature given the small sample size and limited follow-up. Overall, there were 16 complications, but only two of these, an orbital hematoma and a frontal lobe abscess, were considered major complications directly attributable to surgery. Conclusions: TER for ASB tumors appears to be safe in properly selected patients. In light of the small sample size and limited follow-up, the major complication rate directly attributable to surgery was 11 percent, and the overall local control rate was 95 percent. A larger multi-institutional series with longer follow-up is warranted.

Original languageEnglish
Pages (from-to)920-927
Number of pages8
JournalOtolaryngology - Head and Neck Surgery
Volume136
Issue number6
DOIs
StatePublished - Jun 1 2007

Fingerprint

Skull
Skull Base
Safety
Neoplasms
Sample Size
Olfactory Esthesioneuroblastoma
Craniotomy
Frontal Lobe
Tertiary Care Centers
Hematoma
Abscess
Pathology

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors. / Dave, Sandeep P.; Bared, Anthony; Casiano, Roy R.

In: Otolaryngology - Head and Neck Surgery, Vol. 136, No. 6, 01.06.2007, p. 920-927.

Research output: Contribution to journalArticle

@article{80d095e1afc940f4bb91bff5433efe99,
title = "Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors",
abstract = "Objective: To report the surgical outcomes and safety of transnasal endoscopic resection (TER) for anterior skull base (ASB) tumors. Study Design and Setting: A retrospective chart review to identify patients undergoing TER for ASB tumors at a tertiary care medical center between September 1997 and June 2006. Results: Nineteen patients underwent TER for ASB tumors without open craniotomy. There were 17 malignant and two benign lesions. Olfactory neuroblastoma was the most common pathology, occurring in 53 percent of patients. One patient recurred locally, resulting in an overall local control rate of 94.7 percent for all neoplasms and 94.1 percent for malignant disease. It should be noted that the tumor control rate may be premature given the small sample size and limited follow-up. Overall, there were 16 complications, but only two of these, an orbital hematoma and a frontal lobe abscess, were considered major complications directly attributable to surgery. Conclusions: TER for ASB tumors appears to be safe in properly selected patients. In light of the small sample size and limited follow-up, the major complication rate directly attributable to surgery was 11 percent, and the overall local control rate was 95 percent. A larger multi-institutional series with longer follow-up is warranted.",
author = "Dave, {Sandeep P.} and Anthony Bared and Casiano, {Roy R}",
year = "2007",
month = "6",
day = "1",
doi = "10.1016/j.otohns.2007.01.012",
language = "English",
volume = "136",
pages = "920--927",
journal = "Otolaryngology - Head and Neck Surgery (United States)",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Surgical outcomes and safety of transnasal endoscopic resection for anterior skull tumors

AU - Dave, Sandeep P.

AU - Bared, Anthony

AU - Casiano, Roy R

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Objective: To report the surgical outcomes and safety of transnasal endoscopic resection (TER) for anterior skull base (ASB) tumors. Study Design and Setting: A retrospective chart review to identify patients undergoing TER for ASB tumors at a tertiary care medical center between September 1997 and June 2006. Results: Nineteen patients underwent TER for ASB tumors without open craniotomy. There were 17 malignant and two benign lesions. Olfactory neuroblastoma was the most common pathology, occurring in 53 percent of patients. One patient recurred locally, resulting in an overall local control rate of 94.7 percent for all neoplasms and 94.1 percent for malignant disease. It should be noted that the tumor control rate may be premature given the small sample size and limited follow-up. Overall, there were 16 complications, but only two of these, an orbital hematoma and a frontal lobe abscess, were considered major complications directly attributable to surgery. Conclusions: TER for ASB tumors appears to be safe in properly selected patients. In light of the small sample size and limited follow-up, the major complication rate directly attributable to surgery was 11 percent, and the overall local control rate was 95 percent. A larger multi-institutional series with longer follow-up is warranted.

AB - Objective: To report the surgical outcomes and safety of transnasal endoscopic resection (TER) for anterior skull base (ASB) tumors. Study Design and Setting: A retrospective chart review to identify patients undergoing TER for ASB tumors at a tertiary care medical center between September 1997 and June 2006. Results: Nineteen patients underwent TER for ASB tumors without open craniotomy. There were 17 malignant and two benign lesions. Olfactory neuroblastoma was the most common pathology, occurring in 53 percent of patients. One patient recurred locally, resulting in an overall local control rate of 94.7 percent for all neoplasms and 94.1 percent for malignant disease. It should be noted that the tumor control rate may be premature given the small sample size and limited follow-up. Overall, there were 16 complications, but only two of these, an orbital hematoma and a frontal lobe abscess, were considered major complications directly attributable to surgery. Conclusions: TER for ASB tumors appears to be safe in properly selected patients. In light of the small sample size and limited follow-up, the major complication rate directly attributable to surgery was 11 percent, and the overall local control rate was 95 percent. A larger multi-institutional series with longer follow-up is warranted.

UR - http://www.scopus.com/inward/record.url?scp=34249784537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249784537&partnerID=8YFLogxK

U2 - 10.1016/j.otohns.2007.01.012

DO - 10.1016/j.otohns.2007.01.012

M3 - Article

C2 - 17547980

AN - SCOPUS:34249784537

VL - 136

SP - 920

EP - 927

JO - Otolaryngology - Head and Neck Surgery (United States)

JF - Otolaryngology - Head and Neck Surgery (United States)

SN - 0194-5998

IS - 6

ER -